1. Home
  2. BLOG

BLOG

Stem Cell Therapeutics Nabs Sirpa Protein-Targeting Mabs – News-Medical.net

Stem Cell Therapeutics Nabs Sirpa Protein-Targeting MabsNews-Medical.netBiopharmaceutical immuno-oncology company Stem Cell Therapeutics (SCT) has entered an agreement to exclusively license worldwide rights to a panel of fully human monoclonal antibodies targeting the SIRPa protein (CD172a). This technology was …Stem Cell Therapeutics Strengthens CD47 Franchise With Acquistion of …Stockhouse all 4 news articles …read more   &nbs… Continue reading

2013-10-17 NEWS

Biomanufacturing center takes central role in developing stem-cell therapies – University of Wisconsin-Madison

Biomanufacturing center takes central role in developing stem–cell therapiesUniversity of Wisconsin-MadisonA Waisman Biomanufacturing specialist examines cells in a culture in the cell therapy clean room. The UW-Madison Waisman Center opened Waisman Biomanufacturing to ease the research and development of biological products and drugs. …read more   &nbs… Continue reading

2013-10-17 NEWS

Stem Cell Therapeutics Strengthens CD47 Franchise With Acquistion of … – Marketwired (press release)

Stem Cell Therapeutics Strengthens CD47 Franchise With Acquistion of …Marketwired (press release)(TSX VENTURE:SSS)(OTCQX:SCTPF), a biopharmaceutical immuno-oncology company developing cancer stem cell-related therapeutics, today announced that it has entered into an option agreement to exclusively license worldwide rights to a panel of fully … and more …read more   &nbs… Continue reading

2013-10-17 NEWS

Stem cell agency president to resign, return to Australia – San Francisco Business Times (blog)

Stem cell agency president to resign, return to AustraliaSan Francisco Business Times (blog)Alan Trounson, the Australian biologist turned administrator of California’s stem cell research funding agency, will resign after six years on the job, the organization said Wednesday. Trounson said he wants to spend more time with his family, which … …read more   &nbs… Continue reading

2013-10-17 NEWS

Key stem cell patents are approved for Cellular Dynamics – 77Square.com

Key stem cell patents are approved for Cellular Dynamics77Square.comCellular Dynamics International (CDI), the Madison stem cell company founded by UW stem cell researcher James Thomson, has received two patents this month that protect critical technology the company uses in its production methods. Most recently, the …Cellular Dynamics issued patent for blood vessel, blood cell technologyThe … Continue reading

2013-10-16 NEWS